QMed Long Term Debt 2010-2009 | QMED

QMed long term debt from 2010 to 2009. Long term debt can be defined as the sum of all long term debt fields.
QMed Annual Long Term Debt
(Millions of US $)
QMed Quarterly Long Term Debt
(Millions of US $)
2009-08-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
QMed, Inc. is a proprietary medical information technology bringing combined patient-specific prognosis and national standard therapeutic recommendations to primary care doctors, while incorporating process reports of expense and health outcomes for managed care organizations. Thiscost- effective system, subject of an article submitted to a prestigious medical journal, is employed by Regence BlueCross BlueShield, PacifiCare Health Systems, CHA Health, DAKOTACARE, and CIGNA HealthCare. QMed also designs and markets diagnostic medical devices. (PRESS RELEASE)
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.606B 24.25
Becton Dickinson (BDX) United States $47.863B 11.85
Cardinal Health (CAH) United States $36.277B 19.00
Labcorp (LH) United States $20.659B 16.76
Straumann Holding AG (SAUHY) Switzerland $19.996B 0.00
Cooper (COO) United States $16.312B 21.64
West Pharmaceutical Services (WST) United States $15.158B 31.77
Align Technology (ALGN) United States $13.003B 25.56
Henry Schein (HSIC) United States $8.157B 13.90
Merit Medical Systems (MMSI) United States $5.552B 26.84
DENTSPLY SIRONA (XRAY) United States $2.758B 8.29
CONMED (CNMD) United States $1.763B 13.19
STAAR Surgical (STAA) United States $0.940B 0.00
Lifevantage (LFVN) United States $0.148B 16.36
Pro-Dex (PDEX) United States $0.147B 16.05